Skip to content

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia.

L A Núñez, M Gurpegui

Acta Psychiatrica Scandinavica March 1, 2002 DOI: 10.1034/j.1600-0447.2002.1o079.x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Cross-sectional Peer reviewed
Sample size 61
Population Patients with cannabis-induced psychosis or acute schizophrenia, confirmed by repeated urine screens for cannabis consumption
Duration At least 1 week but not more than 1 month of abstinence for cannabis-induced psychosis group
Topics Cannabis
Key findings Cannabis-induced psychosis and acute schizophrenia have distinct demographic, premorbid, and clinical features, supporting cannabis-induced psychosis as a separate clinical entity.

Abstract

The existence of cannabis-induced psychosis (CP) remains controversial, partly because of methodological problems. We hypothesize that acute schizophrenia (AS) and CP can have distinct demographic, premorbid and clinical features. We compared 26 patients with CP to 35 with AS, after their cannabis-consumption status was confirmed by repeated urine screens. Patients with CP were assessed after at least 1 week but not more than 1 month of abstinence. Symptoms were evaluated with the Present State Examination (PSE). In group CP, male gender, expansive mood and ideation, derealization/depersonalization, visual hallucinations, and disturbances of sensorium were more frequent than in group AS. Premorbid schizoid personality traits were more frequently associated to AS and antisocial personality traits to CP. The continuous heavy use of cannabis can induce a psychotic disorder distinct from AS. These two clinical entities share some features but they differ in others.

Comparable studies

Other observational and cohort studies on cannabis, most cited first.

Study Year Design Participants
High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population 2009 Case-control study n = 454
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population 2013 Observational study
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people 2000 Observational
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline 2011 Observational cohort n = 1,923
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... 2005 Observational cohort n = 535

Citations in the library

Explore topics